Silvercrest Asset Management Group LLC Bicycle Therapeutics PLC Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q4 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 137,740 shares of BCYC stock, worth $1.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
137,740
Previous 139,093
0.97%
Holding current value
$1.61 Million
Previous $3.15 Million
38.87%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
42.9MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$127 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$53.1 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$40.3 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.61MShares$30.4 Million0.17% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$25.6 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $346M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...